February 2019 - GU CONNECT

An update on the treatment of patients with mCRPC with RA-223 plus AAP

by healios | Feb 14, 2019 | your clinical answers

An update on the treatment of patients with mCRPC with RA-223 plus AAP Dr. Tia Higano provides her perspective on ERA 223: A phase 3 trial of Ra-223 in combination with AAP in the treatment of asymptomatic or mildly symptomatic chemotherapy-naïve patients with...

Advanced PET Imaging in Prostate Cancer

by healios | Feb 11, 2019 | useful ressources

Advanced PET Imaging in Prostate Cancer Dr. Phillip J. Koo provides his thoughts on the use of advanced PET imaging in prostate cancer Download the slides Share feedback Learn more about this topic with Prof. Evan Y. Yu and his perspective on non-metastatic...

GU CONNECT Update from ESMO 2018

by healios | Feb 14, 2019 | gu updates

GU CONNECT Update from ESMO 2018 GU CONNECT has summarised the highlights from ESMO 2018 for you. GU oncology by Dr. Fabio Schutz, Beneficencia Portuguesa de Sao Paulo, Brazil Download the...

Advances in metastatic hormone-sensitive prostate cancer

by healios | Feb 14, 2019 | your clinical answers

Advances in metastatic hormone-sensitive prostate cancer Associate Professor Alicia Morgans provides her thoughts on the recent advances in metastatic hormone-sensitive prostate cancer Download the slides Advances in metastatic hormone-sensitive prostate cancer...

How to use combination, sequential and immuno-oncology therapies in mCRPC?

by healios | Feb 14, 2019 | your clinical answers

How to use combination, sequential and immuno-oncology therapies in mCRPC? Professor of Medicine Evan Yu and Associate Professor Tanya Dorff provide their thoughts and views on combination, sequential and immuno-oncology therapies in mCRPC (Metastatic...

« Older Entries

An update on the treatment of patients with mCRPC with RA-223 plus AAP

Advanced PET Imaging in Prostate Cancer

GU CONNECT Update from ESMO 2018

Advances in metastatic hormone-sensitive prostate cancer

How to use combination, sequential and immuno-oncology therapies in mCRPC?

Recent Posts

Recent Comments

Archives

Categories

Meta

Are you a healthcare professional?

Thanks for visiting this website